Results 101 to 110 of about 31,242 (231)

Unveiling New Insights: Reinterpreting DES Mutation, p.Arg383His, Through a Study of an Iranian Family With Isolated Hypertrophic Cardiomyopathy, Implication for Phenotype–Genotype Correlation Analysis

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Desmin, a crucial intermediate filament in muscle cells, maintains structural integrity in cardiac muscle and provides stability to striated muscle cells. Mutations in the DES gene lead to desminopathies, causing diverse cardiac and skeletal myopathies.
Saeideh Kavousi, Farzad Kamali, Bahareh Rabbani, Mehrdad Behmanesh, Nejat Mahdieh, Mehrdad Noruzinia   +5 more
wiley   +1 more source

Mortality Related to Different Circulatory Diseases Before, During and After the COVID‐19 Pandemic

Clinical Cardiology, Volume 49, Issue 8, August 2026.
The COVID‐19 pandemic triggered significant mortality spikes for circulatory diseases (IHD, CVD, HD, and AF) in Veneto between 2020 and 2022. However, by 2023, mortality rates for all conditions realigned with pre‐pandemic historical trends, indicating that the long‐term impact on cardiovascular mortality remained limited. ABSTRACT Background The COVID‐
Giulia Capodaglio, Ugo Fedeli, Susanna Levantesi, Paolo Girardi   +3 more
wiley   +1 more source

Thromboprophylaxis for atrial flutter [PDF]

European Heart Journal, 2001
G Y, Lip, S, Kamath
openaire   +2 more sources

Polypharmacy burden and incident epilepsy among older adults in the United States

Epilepsia Open, Volume 11, Issue 4, Page 1370-1381, August 2026.
Abstract Objectives To estimate the prevalence of polypharmacy among older adults with incident epilepsy and to describe the most common combinations of drug classes filled prior to epilepsy diagnosis. Polypharmacy—the concurrent use of multiple medications—is common in older adults with epilepsy, but little is known about its burden and specific ...
Galen Shearn‐Nance, Long Vu, Hannah L. Fein, Wyatt P. Bensken, Jorden G. Rieke, Martha Sajatovic, Gena Ghearing, David F. Warner, Siran M. Koroukian, Nicholas K. Schiltz   +9 more
wiley   +1 more source

Pre‐Infection COVID‐19 Vaccination and Long‐Term Cardiovascular Outcomes in Adults Without Preexisting Cardiovascular Disease: A Retrospective Cohort Study

Health Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background Long‐term cardiovascular complications after COVID‐19 are increasingly recognized, yet the protective effect of pre‐infection vaccination in individuals without prior cardiovascular disease (CVD) remains unclear. This study examined the association between COVID‐19 vaccination and major cardiovascular and related outcomes up to 3 ...
Abdul Qadeer, Muneeb Khawar, Michele Fouad, Samiksha Jain, Prutha Pathak, Awon Muhammad, Anu Radha Twayana, Kamel Ikbariah, Najam Gohar, Mueed Chaudhary, Elham Shenawa, Mirza Muhammad Hadeed Khawar   +11 more
wiley   +1 more source

Atrial High‐Rate Episodes Mirror Atrial Fibrillation in Stroke Prediction: Evidence From an Indian Prospective Cohort

Journal of Arrhythmia, Volume 42, Issue 4, August 2026.
This prospective matched cohort study, which generates hypotheses, finds that device‐detected AF lasting under 24 h is linked to a notably increased risk of stroke/TIA and progression to clinical AF among Indian patients. ABSTRACT Aims To assess the risk of stroke/TIA and progression to atrial fibrillation (AF) in Indian patients with device‐detected ...
Sedhupathi Shanmugam, Sreevilasam P. Abhilash, Jyothi Vijay, Sapna erat Sreedharan, Narayanan Namboodiri   +4 more
wiley   +1 more source

Predictors and Outcomes of 30‐Day Readmissions Following Electrical Cardioversion for Atrial Fibrillation: Insights From the Nationwide Readmissions Database

Journal of Arrhythmia, Volume 42, Issue 4, August 2026.
Among 134 114 atrial fibrillation hospitalizations treated with electrical cardioversion in the 2016–2017 NRD, 9.9% resulted in 30‐day readmission. Readmission was associated with higher mortality, longer stay and greater costs. Predictors included cardiometabolic comorbidities, female sex, lower income, Medicare/Medicaid insurance, nonhome discharge ...
Adeena Jamil, Muhammad Umer Sohail, Asad Ali Ahmed Cheema, Syed Usama Ashraf, Anushah Faheem Ilyas, Faizan Abbas, Shaikh Jehanzaib Saeed, Mohammad Rayyan Faisal, Ahmad Murtaza Anwar, Shanzey Rai, Syeda Unzila Tirmizi, Muhammad Uzair, Tooba Shahzad   +12 more
wiley   +1 more source

Documented Obstructive Sleep Apnea, Cardiometabolic Phenotype, and Rhythm‐Related Outcomes After Atrial Fibrillation Ablation: An Observational Cohort Study

Journal of Arrhythmia, Volume 42, Issue 4, August 2026.
Documented OSAS identified a higher‐risk cardiometabolic phenotype in patients undergoing AF ablation, including greater obesity, hypertension, diabetes, persistent AF, and adverse lipid markers. However, it did not independently predict post‐ablation rhythm‐related outcomes in either the registry cohort or the actively followed cohort.
Yazan Mohsen, Iryna Novikov, Shreeram Sabareesan, Kensuke Sakata, Moritz Knitter, Henning Horlitz, Lucas Steffens, Marc Horlitz, Ibrahim Antoun, Florian Stöckigt   +9 more
wiley   +1 more source

Lifestyle Factors and Thromboembolic Risk in Atrial Fibrillation: Age‐Dependent Effects of Smoking and Alcohol Consumption

Journal of Arrhythmia, Volume 42, Issue 4, August 2026.
Association of current smoking and daily alcohol consumption with cardioembolic stroke in patients with atrial fibrillation. ABSTRACT Background Atrial fibrillation (AF) relates to cardioembolic stroke (CS), but the role of lifestyle factors, including smoking and alcohol, remains unclear.
Masamichi Yano, Yasuyuki Egami, Mikako Kise, Taichi Mukai, Noriyuki Kobayashi, Ayako Sugino, Masaru Abe, Hiroaki Nohara, Shodai Kawanami, Koji Yasumoto, Naotaka Okamoto, Yasuharu Matsunaga‐Lee, Masami Nishino   +12 more
wiley   +1 more source

Utility of Post‐Procedural HFA‐PEFF Reassessment for Long‐Term Heart Failure Risk Stratification After Atrial Fibrillation Ablation

Journal of Arrhythmia, Volume 42, Issue 4, August 2026.
In this single‐center cohort of 856 patients with preserved left ventricular ejection fraction undergoing atrial fibrillation ablation, post‐procedural HFA‐PEFF reassessment provided better long‐term discrimination for heart failure hospitalization than pre‐procedural assessment over a median 5.2‐year follow‐up.
Hironori Ishiguchi, Yasuhiro Yoshiga, Masakazu Fukuda, Shintaro Hashimoto, Goki Nakashima, Takuya Omuro, Akihiko Shimizu, Motoaki Sano   +7 more
wiley   +1 more source